Next Article in Journal
“Just Caring”: Can We Afford the Ethical and Economic Costs of Circumventing Cancer Drug Resistance?
Previous Article in Journal
Motivations and Barriers to Sharing Biological Samples: A Case Study
J. Pers. Med. 2013, 3(2), 111-123; doi:10.3390/jpm3020111
Article

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information

1,2,* , 1,3
 and 1,4
1 Medco Research Institute, LLC, Medco Health Solutions, Inc., Bethesda, MD 20814, USA 2 EJS Health Solutions, LLC, 1653 Pennfield Drive Thorofare, West Deptford, NJ 08086, USA 3 Biocerna, LLC, Gaithersburg, MD 20879, USA 4 Opus Three, LLC, Gaithersburg, MD 20878, USA
* Author to whom correspondence should be addressed.
Received: 17 April 2013 / Revised: 24 May 2013 / Accepted: 4 June 2013 / Published: 10 June 2013
View Full-Text   |   Download PDF [427 KB, uploaded 10 June 2013]

Abstract

We surveyed 10,303 United States physicians on where they obtain pharmacogenomic testing information. Thirty-nine percent indicated that they obtained this from drug labeling. Factors positively associated with this response included older age, postgraduate instruction, using other information sources, regulatory approval/ recommendation of testing, reliance on labeling for information, and perception that patients have benefited from testing. Physicians use pharmacogenomic testing information from drug labeling, highlighting the importance of labeling information that is conducive to practice application.
Keywords: pharmacogenomics; physician; drug labeling; survey pharmacogenomics; physician; drug labeling; survey
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

Stanek, E.J.; Sanders, C.L.; Frueh, F.W. Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. J. Pers. Med. 2013, 3, 111-123.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert